The role of aromatic side chain residues in micelle binding by pancreatic colipase. Fluorescence studies of the porcine and equine proteins.
Fluorescence techniques have been employed to study the interaction of porcine and equine colipase with pure taurodeoxycholate and mixed micelles. Nitrotyrosine-55 of porcine colipase is obtained by modification with tetranitromethane (low excess, in the presence of taurodeoxycholate) of the protein followed by gel filtration and ion-exchange chromatography. Verification of the residue modified was obtained by h.p.l.c. peptide purification and sequence analysis. Reduction and quantitative reaction with dansyl chloride yields a fluorescent derivative that is twice as active in conjunction with lipase as is native colipase and that exhibits a strong emission band at 550 nm. Addition of micellar concentrations of taurodeoxycholate causes a 4.3-fold increase in the emission maximum as well as a 70 nm blue shift to 480 nm. Inclusion of oleic acid to form a mixed micelle reduces these spectral effects. Scatchard analysis of the data yield a Kd of 6.8 X 10(-4) M and a single colipase-binding site for taurodeoxycholate micelles. The data, by analogy to a phospholipase system, are consistent with a direct insertion of dansyl-NH-tyrosine-55 into the micelle. The presence of a single tryptophan residue (Trp-52) in equine colipase provides an intrinsic fluorescent probe for studying protein-micelle interaction. The emission maximum of horse colipase at 345 nm indicates a solvent-accessible tryptophan residue which becomes less so on binding of micelles. A blue shift of 8 nm and a 2-fold increase in amplitude is indicative of a more hydrophobic environment for tryptophan induced by taurodeoxycholate micelles. There is also a decrease in KSV for acrylamide quenching in the presence of micelles, which further supports a loss of solvent accessibility. The most dramatic pH effects are observed with KI quenching, and may indicate the presence of negative charges near Trp-52.
McIntyre
J C
JC
Department of Biochemistry and Molecular Biology, University of Cincinnati College of Medicine, OH 45267.
Hundley
P
P
Behnke
W D
WD
D020106:Acrylamide; D000178:Acrylamides / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002586:Cesium / Q000494:pharmacology; D002712:Chlorides; D003089:Colipases / Q000378:metabolism*; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D006736:Horses; D007700:Kinetics; D008823:Micelles; D010179:Pancreas / Q000378:metabolism*; D011193:Potassium Iodide / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D011506:Proteins / Q000378:metabolism*; D013050:Spectrometry, Fluorescence; D013329:Structure-Activity Relationship; D013552:Swine; D013657:Taurodeoxycholic Acid / Q000378:metabolism*; D014364:Tryptophan / Q000031:analogs & derivatives / Q000032:analysis* / Q000378:metabolism
D000178:Acrylamides; D002712:Chlorides; D003089:Colipases; D008823:Micelles; D011506:Proteins; D003840:Deoxycholic Acid; D011193:Potassium Iodide; D002586:Cesium; D020106:Acrylamide; C016952:N-acetyltryptophanamide; D013657:Taurodeoxycholic Acid; D014364:Tryptophan; C028019:cesium chloride